Crestor
Tim Calkins, Joshua Neiman · Kellogg School of Management Cases · 2017
AstraZeneca is preparing for the launch of Crestor, the company's first entrant in the enormous and fast-growing statin category. The team responsible for the product launch is considering how best to bring Crestor to market. Should AstraZeneca simply follow the example set by Pfizer with the exceptionally successful launch of Lipitor? Or should the company instead launch Crestor as a niche product? To teach new product strategy for both emerging and established categories, and competitive strategy.
Cited by 2 works. doi:10.1108/case.kellogg.2016.000084